Two independent studies demonstrated that blockade of the CXCL12/CXCR4 axis improved the functional outcome after stroke by attenuating post-ischemic inflammation (Huang et al., 2013; Ruscher et al., 2013). Here, CXCR4 is linked to stroke disorder.